BNT162b2 vaccine booster dose did not influence the activity of the exudative form of age-related macular degeneration during anti-vascular endothelial growth factor therapy
These results demonstrate that the BNT162b2 vaccine booster dose did not deteriorate the course of neovascular AMD.
Authors
- Dominik Odrobina (ORCID: https://orcid.org/0000-0003-1528-2103)
- Bernadetta Płatkowska-Adamska (ORCID: https://orcid.org/0000-0003-0289-7168)
- Magdalena Kal (ORCID: https://orcid.org/0000-0003-1090-1542)
- Arkadiusz Bociek (ORCID: https://orcid.org/0000-0002-0356-8211)
- Dorota Zarębska‐Michaluk (ORCID: https://orcid.org/0000-0003-0938-1084)
Institutions
- Kielce University of Technology (PL)
- Jan Kochanowski University (PL)
Publication Details
- Journal
- Minerva Medica
- Published
- 2024-10-11
- DOI
- https://doi.org/10.23736/s0026-4806.24.09379-0
- Primary Topic
- Retinal and Optic Conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00